介质干细胞衍生的细胞外囊在糖尿病神经病的治疗应用;挑战和未来前景
Lei Shi1, Hong Xia Che1, Huan Yang1
1Endocrinology Department, The Third People's Hospital of Gansu Province, Lanzhou, China.
Journal of biochemical and molecular toxicology
|August 25, 2025
概括
介质干细胞衍生的细胞外囊 (MSC-EV) 为糖尿病神经病 (DN) 提供了有前途的无细胞疗法. 这些EV重新编程受损细胞,启动再生并缓解与糖尿病相关的并发症.
科学领域:
- 生物医学科学
- 复原医学
- 细胞生物学
背景情况:
- 糖尿病神经病变 (DN) 是糖尿病的主要微血管并发症,对患者的生活质量产生重大影响.
- 目前对DN的治疗方法往往不够,强调需要新的治疗策略.
- 介质干细胞 (MSC) 已成为糖尿病及其并发症的潜在治疗方法.
研究的目的:
- 为治疗糖尿病神经病 (DN) 提供介质干细胞衍生的细胞外囊 (MSC-EVs) 的综合性审查.
- 讨论使用MSC-EVs用于DN治疗的最新进展和挑战.
- 探索MSC-EV作为DN的无细胞治疗方法的潜力.
主要方法:
- 在糖尿病神经病情背景下研究MSC-EV的文献综述.
- 分析研究表明MSC-EV具有治疗效果的机制.
- 对MSC-EV治疗的有效性和挑战的最新发现的综合.
主要成果:
- 来自MSC的细胞外囊泡 (MSC- EVs) 显示出作为DN的无细胞疗法的显著潜力.
- 在受损组织中,MSC-EV可促进细胞重编程和启动再生过程.
- 这些囊泡转移生物活性分子,创造有益的微环境,有助于缓解并发症.
结论:
- 对于治疗糖尿病神经病症而言,MSC-EV是一种新且有前途的治疗途径.
- 为了克服挑战并优化MSC-EV在临床环境中的有效性,进一步的研究和开发至关重要.
- MSC-EVs的无细胞性质为DN的治疗应用提供了优势.
更多相关视频
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
3.1K
09:10A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
Published on: June 23, 2022
1.6K
相关概念视频
01:19Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K